Dickkopf 4 (DKK4) acts on Wnt/Β-catenin pathway by influencing Β-catenin in hepatocellular carcinoma

Oncogene

Volumn 31, Issue 38, 2012, Pages 4233-4244

  Fatima, S ^a   Lee, N P ^a   Tsang, F H ^a   Kolligs, F T ^b   Ng, I O L ^a   Poon, R T P ^a   Fan, S T ^a   Luk, J M ^a,c,d,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^e PRED China   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; LUCIFERASE; PROTEASOME; PROTEASOME INHIBITOR; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL ASSAY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DICKKOPF 4 GENE; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; TUMOR XENOGRAFT; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; SIGNAL TRANSDUCTION; WNT PROTEINS;

MUS MUSCULUS;

EID: 84866549389     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.580     Document Type: Article

References (70)

1. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J et al. (2006). Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25: 4116-4121. (Pubitemid 44024874)
2. Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP. (2008). Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 47: 288-295. (Pubitemid 351171066)
3. Baehs S, Herbst A, Thieme SE, Perschl C, Behrens A, Scheel S et al. (2009). Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells. Cancer Lett 276: 152-159.
4. Blitzer JT, Nusse R. (2006). A critical role for endocytosis in Wnt signaling. BMC Cell Biol 7: 28.
5. Chamorro MN, Schwartz DR, Vonica A, Brivanlou AH, Cho KR, Varmus HE. (2005). FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development. EMBO J 24: 73-84. (Pubitemid 40188465)
6. Chen TC, Hsieh LL, Ng KF, Jeng LB, Chen MF. (1998). Absence of APC gene mutation in the mutation cluster region in hepatocellular carcinoma. Cancer Lett 134: 23-28.
7. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O et al. (1998). Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851. (Pubitemid 28350577)
8. Dignam JD, Lebovitz RM, Roeder RG. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489.
9. Ding Z, Qian YB, Zhu LX, Xiong QR. (2009). Promoter methylation and mRNA expression of DKK-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol 15: 2595-2601.
10. Fatima S, Lee NP, Luk JM. (2011). Dickkopfs and Wnt/beta-catenin signalling in liver cancer. World J Clin Oncol 2: 311-325.
11. Gonzalez FJ. (2006). Role of beta-catenin in the adult liver. Hepatology 43: 650-653.
12. Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, Cal S et al. (2005). The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 24: 1098-1103. (Pubitemid 40313887)
13. Hao K, Luk JM, Lee NP, Mao M, Zhang C, Ferguson MD et al. (2009). Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer 9: 389.
14. Hirata H, Hinoda Y, Majid S, Chen Y, Zaman MS, Ueno K et al. (2011). DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma. Cancer 117: 1649-1660.
15. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K et al. (2009). Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin Cancer Res 15: 5678-5687.
16. Hu J, Dong A, Fernandez-Ruiz V, Shan J, Kawa M, Martinez-Anso E et al. (2009). Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res 69: 6951-6959.
17. Huang H, Fujii H, Sankila A, Mahler-Araujo BM, Matsuda M, Cathomas G et al. (1999). Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 155: 1795-1801.
18. Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J et al. (2002). Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 8: 450-456. (Pubitemid 34193964)
19. Ishii H, Baffa R, Numata SI, Murakumo Y, Rattan S, Inoue H et al. (1999). The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors. Proc Natl Acad Sci USA 96: 3928-3933. (Pubitemid 29169013)
20. Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS et al. (2008). RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14: 226-237.
21. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. (2011). Global cancer statistics. CA Cancer J Clin 61: 69-90.
22. Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. (2005). Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol 20: 873-881. (Pubitemid 40897168)
23. Krieghoff E, Behrens J, Mayr B. (2006). Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 119: 1453-1463.
24. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L et al. (1999). Functional and structural diversity of the human Dickkopf gene family. Gene 238: 301-313. (Pubitemid 29447031)
25. Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J et al. (2009a). Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 124: 287-297.
26. Lee NP, Chen L, Lin MC, Tsang FH, Yeung C, Poon RT et al. (2009b). Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma. J Proteome Res 8: 1293-1303.
27. Lee NP, Leung KW, Cheung N, Lam BY, Xu MZ, Sham PC et al. (2008). Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma. Proteomics 8: 2136-2149. (Pubitemid 351775792)
28. Lee NP, Tong MK, Leung PP, Chan VW, Leung S, Tam PC et al. (2006). Kidney claudin-19: localization in distal tubules and collecting ducts and dysregulation in polycystic renal disease. FEBS Lett 580: 923-931. (Pubitemid 43152316)
29. Lee NP, Tsang FH, Shek FH, Mao M, Dai H, Zhang C et al. (2010). Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma. Int J Cancer 127: 968-976.
30. Liao C, Zhao M, Song H, Uchida K, Yokoyama KK, Li TP. (2000). Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology 32: 721-727.
31. Liao CH, Yeh CT, Huang YH, Wu SM, Chi HC, Tsai MM et al. (2011). Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells. Hepatology.
32. Liu AM, Poon RT, Luk JM. (2010). MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 394: 623-627.
33. Liu LX, Lee NP, Chan VW, Xue W, Zender L, Zhang C et al. (2009). Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 50: 1453-1463.
34. Logan CY, Nusse R. (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810. (Pubitemid 39488658)
35. Lu WJ, Lee NP, Kaul SC, Lan F, Poon RT, Wadhwa R et al. (2011). Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Int J Cancer 129: 1806-1814.
36. MacDonald BT, Tamai K, He X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
37. Maehata T, Taniguchi H, Yamamoto H, Nosho K, Adachi Y, Miyamoto N et al. (2008). Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer. World J Gastroenterol 14: 2702-2714.
38. Mao B, Niehrs C. (2003). Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302: 179-183. (Pubitemid 36078410)
39. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM et al. (2002). Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417: 664-667. (Pubitemid 34614827)
40. Mao BY, Wu W, Li Y, Hoppe D, Stannek P, Glinka A et al. (2001). LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411: 321-325. (Pubitemid 32467039)
41. Matsui A, Yamaguchi T, Maekawa S, Miyazaki C, Takano S, Uetake T et al. (2009). DICKKOPF-4 and-2 genes are upregulated in human colorectal cancer. Cancer Sci 100: 1923-1930.
42. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. (1997). Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790. (Pubitemid 27136715)
43. Nakamura T, Matsumoto K. (2008). The functions and possible significance of Kremen as the gatekeeper of Wnt signalling in development and pathology. J Cell Mol Med 12: 391-408. (Pubitemid 351555123)
44. Nejak-Bowen KN, Monga SP. (2011). Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol 21: 44-58.
45. Niehrs C. (2006). Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25: 7469-7481. (Pubitemid 44885746)
46. Niida A, Hiroko T, Kasai M, Furukawa Y, Nakamura Y, Suzuki Y et al. (2004). DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene 23: 8520-8526. (Pubitemid 39540802)
47. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. (1997). Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272: 24735-24738. (Pubitemid 27415637)
48. Pendas-Franco N, Garcia JM, Pena C, Valle N, Palmer HG, Heinaniemi M et al. (2008). DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene 27: 4467-4477.
49. Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, Weissenbach J et al. (1999). Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene 18: 3127-3134. (Pubitemid 29261233)
50. Sakanaka C. (2002). Phosphorylation and regulation of beta-catenin by casein kinase I epsilon. J Biochem 132: 697-703. (Pubitemid 35408491)
51. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S et al. (2007). Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28: 2459-2466. (Pubitemid 350238947)
52. Semenov MV, Tamai K, Brott BK, Kuhl M, Sokol S, He X. (2001). Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11: 951-961. (Pubitemid 32589186)
53. Shih YL, Hsieh CB, Lai HC, Yan MD, Hsieh TY, Chao YC et al. (2007). SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Int J Cancer 121: 1028-1035.
54. Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M et al. (2008). Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma. J Gastroenterol 43: 378-389. (Pubitemid 351958902)
55. Takemaru K, Yamaguchi S, Lee YS, Zhang Y, Carthew RW, Moon RT. (2003). Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway. Nature 422: 905-909. (Pubitemid 36520044)
56. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM et al. (2002). Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Onco-gene 21: 4863-4871. (Pubitemid 34879463)
57. Tung EK, Mak CK, Fatima S, Lo RC, Zhao H, Zhang C et al. (2011). Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int 31: 1494-1504.
58. Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T et al. (2006). Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res 12: 6989-6997. (Pubitemid 44974494)
59. Wiesman KC, Wei L, Baughman C, Russo J, Gray MR, Castellot JJ. (2010). CCN5, a secreted protein, localizes to the nucleus. J Cell Commun Signal 4: 91-98.
60. Wong CM, Fan ST, Ng IO. (2001). beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 92: 136-145. (Pubitemid 32623050)
61. Wu Y, Zhang Y, Zhang H, Yang X, Wang Y, Ren F et al. (2010). p15RS attenuates Wnt/{beta}-catenin signaling by disrupting {beta}-catenin.TCF4 Interaction. J Biol Chem 285: 34621-34631.
62. Yang B, Du Z, Gao YT, Lou C, Zhang SG, Bai T et al. (2010). Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma. World J Gastroenterol 16: 755-763.
63. Yamamoto H, Sakane H, Michiue T, Kikuchi A. (2008). Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling. Dev Cell 15: 37-48. (Pubitemid 351895596)
64. Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY et al. (2008). Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics 7: 315-325. (Pubitemid 351298446)
65. Yu B, Yang X, Xu Y, Yao G, Shu H, Lin B et al. (2009). Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol 50: 948-957.
66. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. (1998). Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58: 2196-2199. (Pubitemid 28232908)
67. Yue W, Sun Q, Dacic S, Landreneau RJ, Siegfried JM, Yu J et al. (2008). Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Carcinogenesis 29: 84-92. (Pubitemid 351201745)
68. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R et al. (2005). A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873-877. (Pubitemid 41753071)
69. Zhang K, Watanabe M, Kashiwakura Y, Li SA, Edamura K, Huang P et al. (2010). Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol 37: 1495-1501.
70. Zhang LH, Qin LX, Ma ZC, Ye SL, Liu YK, Ye QH et al. (2003). Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis. J Cancer Res Clin Oncol 129: 279-286.